|
|
Analysis of influencing factors on non-small cell lung cancer treatment quality based on evaluation indicators |
Li Jingkun, Li Xi, Liu Meina |
Department of Health Statistics, Institute of Public Health, Harbin Medical University, Harbin 150081, China |
|
|
Abstract Objective To analyze the factors that affecting the treatment quality of non-small cell lung cancer based on the treatment quality evaluation indicators of non-small cell lung cancer, and to provide data support for improving the treatment quality of non-small cell lung cancer.Methods Based on the treatment quality evaluation index system of non-small cell lung cancer, we calculated the treatment quality score of patients, and the patients were divided into the high-quality group and the low-quality group with the mean score as the boundary. Single factor and multiple factor logistic regression were used to analyze the influencing factors of the treatment quality of non-small cell lung cancer.Results The mean score of treatment quality for non-small cell lung cancer was 0.67, and the numbers of patients in the high score group and in the low score group were 1 438 and 1 596. The results showed that the influencing factors of treatment quality included age, hospital, occupation, past history, lymph node dissection and pathological stage (P< 0.05). The rate of low quality was 61.92% in general hospitals and 45.42% in specialized hospitals. The treatment quality of elderly patients was poor (OR=2.790 3, 95% CI:1.8511~4.206 1). Patients with previous history (OR=0.787 1, 95% CI:0.671 7~0.922 3) and lymph node dissection (OR=0.592 7, 95% CI:0.407 7~0.861 5) had higher quality scores.Conclusion Analysis of influencing factors on non-small cell lung cancer treatment quality suggests that lymph node dissection has a positive effect on improving the treatment quality of NSCLC, and the specialization of the hospital is conducive to providing more high-quality treatment.
|
Received: 07 June 2018
|
|
|
|
|
[1] SHI W, SONG J, WANG W, et al. MACC1 antibody target therapy suppresses growth and migration of nonsmall cell lung cancer[J]. Molecular Medicine Reports, 2017, 16(5):7329. [2] YANO T, HARO A, YOSHIDA T, et al. Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer[J]. Journal of Surgical Oncology, 2010, 102(7):852-855. [3] OUWENS MM, HEMENS RR, TERMEER RA, et al. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care[J]. Cancer, 2007,110(8):1782-1790. [4] 刘新,沈世林,王玉萍,等.中晚期非小细胞肺癌的综合介入治疗现状[J].中华肺部疾病杂志:电子版,2017,10(4):486-489. [5] 蒋皓,王心雨,苏少飞,等.非小细胞肺癌病人术后生存分析的死亡风险分组研究[J].中国医院统计,2017,24(3):161-164. [6] 张慧敏,包含,付蓉,等.医院结直肠癌治疗质量评价指标体系的建立[J].中国医院统计,2015,22(1):1-4. [7] 苏少飞,刘美娜.基于多维指标的治疗质量综合评价模型构建研究[J].中国卫生统计,2017,34(5):700-704. [8] 李爱武,周彩存,徐建芳,等.年龄与并发症对老年晚期非小细胞肺癌患者治疗和生存期的影响[J].肿瘤,2008, 28(7):596-600. [9] 邵青,杨卫兵.治疗获益的晚期非小细胞肺癌患者生活质量相关影响因素分析[J].遵义医学院学报,2014, 37(1):106-110. [10]1AMR S, WOLPERT B, LOFFREDO CA, et al. Occupation, gender, race, and lung cancer[J]. Journal of Occupational & Environmental Medicine, 2008, 50(10):1167-1175. |
[1] |
Ning Hui, Wang Chao, Wang Yun, Liu Meina. Analysis of influencing factors on treatment quality of acute myocardial infarction based on empirical logit transformation[J]. journal1, 2018, 25(6): 401-404. |
[2] |
. [J]. journal1, 2018, 25(3): 215-217. |
[3] |
Jiang Hao, Wang Xinyu, Su Shaofei, Zhang Meiqi, Wang Jiaying, Li Xi, Liu Meina. Risk grouping after survival analysis of non-small-cell lung cancer surgery patients[J]. journal1, 2017, 24(3): 161-163. |
[4] |
Li Jiandi, Shen Zhihua. Non-conditional logistic regression analysis on the influencing factors of the adverse reaction of ciprofloxacin injection[J]. journal1, 2016, 23(6): 412-414. |
[5] |
Xia Jikai, Shi Dewen, Yang Qinglin, Wang Peiyuan, Zheng Weibo, Li Jun, Yang Minghao. Analysis of status quo of the initiative and its influence factors of Yantai public physical examination[J]. journal1, 2016, 23(3): 192-195. |
[6] |
. [J]. journal1, 2016, 23(1): 38-40. |
|
|
|
|